Article
Targeted inactivation of kinesin-1 in pancreatic β-cells in vivo leads to insulin secretory deficiency.
Diabetes - 1 Jan 2011
Cui Ju, Wang Zai, Cheng Qianni, Lin Raozhou, Zhang Xin-Mei, Leung Po Sing, Copeland Neal G, Jenkins Nancy A, Yao Kwok-Ming, Huang Jian-Dong
Abstract excerpt
OBJECTIVE: Suppression of Kinesin-1 by antisense oligonucleotides, or overexpression of dominant-negative acting kinesin heavy chain, has been reported to affect the sustained phase of glucose-stimulated insulin secretion in β-cells in vitro. In this study, we examined the in vivo physiological r...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
